Thus, considering that CCL-3 marks glial cell activation, an increased CSF level of this cytokine in RRMS is not surprising since astrocyte and microglia activation and proliferation constitute a major histological feature of white and gray matter inflammation in MS (35). Here, CCL3 is linked to myeloid sarcoma.